EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The recent advancement of TCR-T cell therapies for cancer treatment

Xiang Zhao, Shuai Shao, Lanxin Hu

Acta Biochimica et Biophysica Sinica · 2024

DOI: 10.3724/abbs.2024034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Xiang Zhao und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Antigen, T-Cell, Immunotherapy, Adoptive, Antigens, Neoplasm. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive cell therapies involve infusing engineered immune cells into cancer patients to recognize and eliminate tumor cells. Adoptive cell therapy, as a form of living drug, has undergone explosive growth over the past decade. The recognition of tumor antigens by the T-cell receptor (TCR) is one of the natural mechanisms that the immune system used to eliminate tumor cells. TCR-T cell therapy, which involves introducing exogenous TCRs into patients' T cells, is a novel cell therapy strategy. TCR-T cell therapy can target the entire proteome of cancer cells. Engineering T cells with exogenous TCRs to help patients combat cancer has achieved success in clinical trials, particularly in treating solid tumors. In this review, we examine the progress of TCR-T cell therapy over the past five years. This includes the discovery of new tumor antigens, protein engineering techniques for TCR, reprogramming strategies for TCR-T cell therapy, clinical studies on TCR-T cell therapy, and the advancement of TCR-T cell therapy in China. We also propose several potential directions for the future development of TCR-T cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsReceptors, Antigen, T-CellImmunotherapy, AdoptiveAntigens, NeoplasmT-LymphocytesHumansAnimalsProtein Engineering

Stichwörter der Autor:innen

TCRTCR-T cell therapycatch bonddynamic bindingpMHCtumor antigen

Substanzen

Receptors, Antigen, T-CellAntigens, Neoplasm

Zitieren

APA

Zhao, X., Shao, S., & Hu, L. (2024). The recent advancement of TCR-T cell therapies for cancer treatment. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024034

Vancouver

Zhao X, Shao S, Hu L. The recent advancement of TCR-T cell therapies for cancer treatment. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024034

BibTeX
@article{Zhao2024,
  author = {Zhao, Xiang and Shao, Shuai and Hu, Lanxin},
  title = {The recent advancement of TCR-T cell therapies for cancer treatment},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2024},
  doi = {10.3724/abbs.2024034}
}
Kostenlos starten →